
Early-stage and liquid-markets investor in crypto and web3 founders

American Cancer Society venture fund investing in early-stage companies developing cancer therapies and diagnostics

BrightEdge Fund is the mission-driven venture capital arm of the American Cancer Society. It puts money into for-profit companies working on new cancer treatments. Its stated aim is to help cut cancer deaths and advance health equity.
Start-ups building cancer-focused products. The fund has announced co-investment work with Third Rock Ventures on oncology companies.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about BrightEdge Fund.
Similar listings buyers compare against this one.

Early-stage and liquid-markets investor in crypto and web3 founders

Technology investor with separate arms for growth companies, venture funds and sport

European venture capital firm backing communications and computing technology teams in Europe and Israel

UK early-stage investor running SEIS and EIS funds for start-ups and their backers

European venture capital fund backing technology startups from pre-seed through to growth stage

Chicago-area community banking group offering business and personal banking, mortgages and digital services
Everything here links back to the same verified catalogue. Pick your next stop.